指南与共识治疗药物监测与药物基因组学

药物基因组学实施现状:药学实践模型峰会建议的影响

Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model Summit.
指南 / 共识 · Am J Health Syst Pharm · 2019-01-01

本文评估药物基因组学作为新兴科学对药学实践的影响,梳理2011年ASHP药学实践模型峰会147条共识中与基因指导用药相关的条款,并介绍4家已实质性推进药物基因组学实施的机构经验,为其他机构提供框架和资源。结论认为通过药学专业和医疗机构优先推进,药物基因组学将得到推广和落实。

要点

  • 147条共识中1条明确将基于遗传因素调整给药方案列为药师核心活动。
  • 另有9条共识支持将药物基因组学纳入药师提供的全程患者照护。
  • 4家先行机构经验可为其他机构启动药物基因组学实施提供框架。

核心结论

  • 通过药学专业和医疗机构优先推进,药物基因组学将得到推广和落实,从而实现峰会共识中利用患者遗传特征改善医疗的目标。

研究设计与样本

  • 本文为报告与评估性文章,梳理2011年ASHP药学实践模型峰会147条共识中与药物基因组学相关的条款,并介绍4家实施机构的经验。

主要发现

  • 147条共识中1条明确将根据遗传因素调整给药方案列为药师提供药物治疗方案的基本活动。
  • 另有9条共识为将药物基因组学纳入药师提供的患者照护各方面提供额外支持。
  • 生物标志物日益被纳入药品说明书,可帮助药师实现个体化用药、优化治疗并避免不良反应。

关键数值与推荐

  • 2011年ASHP药学实践模型峰会共产生147条优化药学实践的共识声明。
  • 其中1条明确描述基于遗传因素调整给药方案是药师提供药物治疗方案的基本活动。
  • 另有9条共识声明为将药物基因组学纳入药师患者照护各方面提供额外支持。

临床怎么用

  • 药师可依据药品说明书中生物标志物信息个体化调整用药,以优化疗效并避免不良反应。
  • 参考4家先行机构的实施框架和资源,启动本机构的药物基因组学实施。
  • 将基于遗传因素调整给药方案作为药师核心活动纳入药学实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This report examines and evaluates pharmacogenomics as an emerging science as it relates to the Practice Advancement Initiative and its predecessor the Pharmacy Practice Model Initiative's consensus statements for optimal pharmacy practice models. SUMMARY: Pharmacogenomics is one of many emerging sciences to impact medication management and delivery of patient care. Increasingly, biomarkers are included in drug labeling and can assist pharmacists with personalizing medicine to optimize patient therapies and avoid adverse effects. The 2011 ASHP Pharmacy Practice Model Summit generated a list of 147 consensus statements for optimal pharmacy practice. Of these, 1 statement explicitly describes adjustment of drug regimens based on genetic factors as an essential activity of pharmacist-provided drug regimens, and 9 other statements provide additional support for incorporation of this emerging science into all aspects of patient care provided by pharmacists. We describe 4 institutions that have made significant inroads to implementing pharmacogenomics, to provide a framework and serve as resources for other institutions initiating their own pharmacogenomics implementation journeys. CONCLUSION: Through prioritized efforts of the pharmacy profession and health care institutions, pharmacogenomics will be disseminated and implemented, and the goal of the Pharmacy Practice Model Initiative's consensus statements of improving health care using patients' genetic characteristics will be realized.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Valgus J, Weitzel KW, Peterson JF, et al. Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model Summit. Am J Health Syst Pharm. 2019. PMID: 31361863. doi:10.1093/ajhp/zxz024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。